目次

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources

Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights

Chapter 3. Transfection Reagents and Equipment Market Variables, Trends, & Scope
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. Transfection Reagents and Equipment Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic and Social landscape
3.4.2.3. Technological landscape
3.4.2.4. Environmental landscape
3.4.2.5. Legal landscape

Chapter 4. Transfection Reagents and Equipment Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Transfection Reagents and Equipment Market: Product Movement Analysis, 2023 & 2030 (USD Million)
4.3. Reagents
4.3.1. Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Equipment
4.4.1. Software Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Transfection Reagents and Equipment Market: Method Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Transfection Reagents and Equipment Market: Method Movement Analysis, 2023 & 2030 (USD Million)
5.3. Electroporation
5.3.1. Electroporation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Liposomes
5.4.1. Liposomes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Particle Bombardment
5.5.1. Particle Bombardment Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. Microinjection
5.6.1. Microinjection Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.7. Adenoviral Vectors
5.7.1. Adenoviral Vectors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.8. Calcium Phosphate
5.8.1. Calcium Phosphate Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.9. DEAE-dextran
5.9.1. DEAE-dextran Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.10. Magnetic Beads
5.10.1. Magnetic Beads Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.11. Activated Dendrimers
5.11.1. Activated Dendrimers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.12. Laserfection
5.12.1. Laserfection Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Transfection Reagents and Equipment Market: Application Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Transfection Reagents and Equipment Market: Application Movement Analysis, 2023 & 2030 (USD Million)
6.3. Gene Expression Studies
6.3.1. Gene Expression Studies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. Protein Production
6.4.1. Protein Production Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Transgenic Models
6.5.1. Transgenic Models Studies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Therapeutic Delivery
6.6.1. Therapeutic Delivery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7. Cancer Research
6.7.1. Cancer Research Studies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.8. Biomedical Research
6.8.1. Biomedical Research Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Transfection Reagents and Equipment: End Use Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. Transfection Reagents and Equipment Market: End Use Movement Analysis, 2023 & 2030 (USD Million)
7.3. Academic and Research Institutes
7.3.1. Academic and Research Institutes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4. Pharmaceutical and Biotechnological Companies
7.4.1. Pharmaceutical and Biotechnological Companies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Transfection Reagents and Equipment: Regional Estimates & Trend Analysis
8.1. Transfection Reagents and Equipment, By Region, 2023 & 2030 (USD Million)
8.2. North America
8.2.1. North America Transfection Reagents and Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.2.2. U.S.
8.2.2.1. U.S. Transfection Reagents and Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.2.3. Canada
8.2.3.1. Canada Transfection Reagents and Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.2.4. Mexico
8.2.4.1. Mexico Transfection Reagents and Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3. Europe
8.3.1. Europe Transfection Reagents and Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.2. UK
8.3.2.1. UK Transfection Reagents and Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.3. Germany
8.3.3.1. Germany Transfection Reagents and Equipment Market Estimates and Forecasts, 2018- 2030 (USD Million)
8.3.4. Italy
8.3.4.1. Italy Transfection Reagents and Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.5. Spain
8.3.5.1. Spain Transfection Reagents and Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.6. Denmark
8.3.6.1. Denmark Transfection Reagents and Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.7. Sweden
8.3.7.1. Sweden Transfection Reagents and Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.8. Norway
8.3.8.1. Norway Transfection Reagents and Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4. Asia Pacific
8.4.1. Asia Pacific Transfection Reagents and Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4.2. Japan
8.4.2.1. Japan Transfection Reagents and Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4.3. China
8.4.3.1. China Transfection Reagents and Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4.4. India
8.4.4.1. India Transfection Reagents and Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4.5. Australia
8.4.5.1. Australia Transfection Reagents and Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4.6. South Korea
8.4.6.1. South Korea Transfection Reagents and Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4.7. Thailand
8.4.7.1. Thailand Transfection Reagents and Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.5. Latin America
8.5.1. Latin America Transfection Reagents and Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.5.2. Brazil
8.5.2.1. Brazil Transfection Reagents and Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.5.3. Argentina
8.5.3.1. Argentina Transfection Reagents and Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6. Middle East and Africa
8.6.1. Middle East and Africa Transfection Reagents and Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6.2. South Africa
8.6.2.1. South Africa Transfection Reagents and Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6.3. Saudi Arabia
8.6.3.1. Saudi Arabia Transfection Reagents and Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6.4. UAE
8.6.4.1. UAE Transfection Reagents and Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6.5. Kuwait
8.6.5.1. Kuwait Transfection Reagents and Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape
9.1. Recent Developments & Impact Analysis by Key Market Participants
9.2. Company Categorization
9.3. Company Heat Map Analysis
9.4. Company Profiles
9.4.1. Thermo Fisher Scientific, Inc.
9.4.1.1. Participant’s Overview
9.4.1.2. Financial Performance
9.4.1.3. Product Benchmarking
9.4.1.4. Recent Developments/ Strategic Initiatives
9.4.2. Promega Corporation
9.4.2.1. Participant’s Overview
9.4.2.2. Financial Performance
9.4.2.3. Product Benchmarking
9.4.2.4. Recent Developments/ Strategic Initiatives
9.4.3. Lonza
9.4.3.1. Participant’s Overview
9.4.3.2. Financial Performance
9.4.3.3. Product Benchmarking
9.4.3.4. Recent Developments/ Strategic Initiatives
9.4.4. QIAGEN
9.4.4.1. Participant’s Overview
9.4.4.2. Financial Performance
9.4.4.3. Product Benchmarking
9.4.4.4. Recent Developments/ Strategic Initiatives
9.4.5. F. Hoffmann-La Roche Ltd.
9.4.5.1. Participant’s Overview
9.4.5.2. Financial Performance
9.4.5.3. Product Benchmarking
9.4.5.4. Recent Developments/ Strategic Initiatives
9.4.6. Bio-Rad Laboratories Inc.
9.4.6.1. Participant’s Overview
9.4.6.2. Financial Performance
9.4.6.3. Product Benchmarking
9.4.6.4. Recent Developments/ Strategic Initiatives
9.4.7. Merck KGaA
9.4.7.1. Participant’s Overview
9.4.7.2. Financial Performance
9.4.7.3. Product Benchmarking
9.4.7.4. Recent Developments/ Strategic Initiatives
9.4.8. OriGene Technologies Inc
9.4.8.1. Participant’s Overview
9.4.8.2. Financial Performance
9.4.8.3. Product Benchmarking
9.4.8.4. Recent Developments/ Strategic Initiatives
9.4.9. MaxCyte, Inc.
9.4.9.1. Participant’s Overview
9.4.9.2. Financial Performance
9.4.9.3. Product Benchmarking
9.4.9.4. Recent Developments/ Strategic Initiatives
9.4.10. Polyplus
9.4.10.1. Participant’s Overview
9.4.10.2. Financial Performance
9.4.10.3. Product Benchmarking
9.4.10.4. Recent Developments/ Strategic Initiatives